Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Rodés J[au]:

Hepatorenal syndrome. Ginès P et al. Lancet. (2003)

Management of cirrhosis and ascites. Ginès P et al. N Engl J Med. (2004)

Portal hypertension. Bosch J et al. Med Clin North Am. (1989)

Search results

Items: 1 to 50 of 728

1.

The impact of cortisol in steatotic and non-steatotic liver surgery.

Cornide-Petronio ME, Bujaldon E, Mendes-Braz M, Avalos de León CG, Jiménez-Castro MB, Álvarez-Mercado AI, Gracia-Sancho J, Rodés J, Peralta C.

J Cell Mol Med. 2017 Oct;21(10):2344-2358. doi: 10.1111/jcmm.13156. Epub 2017 Apr 4.

2.

The effect of cortisol in rat steatotic and non-steatotic liver transplantation from brain-dead donors.

Jiménez-Castro MB, Negrete-Sánchez E, Casillas-Ramírez A, Gulfo J, Álvarez-Mercado AI, Cornide-Petronio ME, Gracia-Sancho J, Rodés J, Peralta C.

Clin Sci (Lond). 2017 Apr 25;131(8):733-746. doi: 10.1042/CS20160676. Epub 2017 Feb 28.

PMID:
28246131
3.

The Effect of High-Mobility Group Box 1 in Rat Steatotic and Nonsteatotic Liver Transplantation From Donors After Brain Death.

Cornide-Petronio ME, Negrete-Sánchez E, Mendes-Braz M, Casillas-Ramírez A, Bujaldon E, Meroño N, Martínez-Carreres L, Gracia-Sancho J, Rodés J, Jiménez-Castro MB, Peralta C.

Am J Transplant. 2016 Apr;16(4):1148-59. doi: 10.1111/ajt.13560. Epub 2015 Dec 24.

4.

The effect of brain death in rat steatotic and non-steatotic liver transplantation with previous ischemic preconditioning.

Jiménez-Castro MB, Meroño N, Mendes-Braz M, Gracia-Sancho J, Martínez-Carreres L, Cornide-Petronio ME, Casillas-Ramirez A, Rodés J, Peralta C.

J Hepatol. 2015 Jan;62(1):83-91. doi: 10.1016/j.jhep.2014.07.031. Epub 2014 Aug 8.

PMID:
25111175
5.

[Animal experimentation and progress in medicine].

Pons JM, Permanyer-Miralda G, Camí J, Rodés J.

Med Clin (Barc). 2014 Nov 18;143(10):448-54. doi: 10.1016/j.medcli.2014.03.021. Epub 2014 May 20. Spanish. No abstract available.

PMID:
24854194
6.

The effects of glucose and lipids in steatotic and non-steatotic livers in conditions of partial hepatectomy under ischaemia-reperfusion.

Mendes-Braz M, Elias-Miró M, Kleuser B, Fayyaz S, Jiménez-Castro MB, Massip-Salcedo M, Gracia-Sancho J, Ramalho FS, Rodes J, Peralta C.

Liver Int. 2014 Aug;34(7):e271-89. doi: 10.1111/liv.12348. Epub 2013 Nov 20.

PMID:
24107124
7.

Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival.

Barreto R, Fagundes C, Guevara M, Solà E, Pereira G, Rodríguez E, Graupera I, Martín-Llahí M, Ariza X, Cárdenas A, Fernández J, Rodés J, Arroyo V, Ginès P.

Hepatology. 2014 Apr;59(4):1505-13. doi: 10.1002/hep.26687. Epub 2014 Feb 25.

PMID:
24037970
8.

Resistin and visfatin in steatotic and non-steatotic livers in the setting of partial hepatectomy under ischemia-reperfusion.

Elias-Miró M, Mendes-Braz M, Cereijo R, Villarroya F, Jiménez-Castro MB, Gracia-Sancho J, Guixé-Muntet S, Massip-Salcedo M, Domingo JC, Bermudo R, Rodés J, Peralta C.

J Hepatol. 2014 Jan;60(1):87-95. doi: 10.1016/j.jhep.2013.07.041. Epub 2013 Aug 19.

PMID:
23968888
9.

Adiponectin and resistin protect steatotic livers undergoing transplantation.

Jiménez-Castro MB, Casillas-Ramírez A, Mendes-Braz M, Massip-Salcedo M, Gracia-Sancho J, Elias-Miró M, Rodés J, Peralta C.

J Hepatol. 2013 Dec;59(6):1208-14. doi: 10.1016/j.jhep.2013.07.015. Epub 2013 Jul 16.

PMID:
23867317
10.

Current knowledge on oxidative stress in hepatic ischemia/reperfusion.

Elias-Miró M, Jiménez-Castro MB, Rodés J, Peralta C.

Free Radic Res. 2013 Aug;47(8):555-68. doi: 10.3109/10715762.2013.811721. Epub 2013 Jun 26. Review.

PMID:
23738581
11.

[The forgotten clinical investigation].

Pons JM, Rodés J, Andreu A, Arenas J.

Med Clin (Barc). 2013 Apr 15;140(7):325-31. doi: 10.1016/j.medcli.2012.10.011. Epub 2012 Dec 13. Spanish. No abstract available.

PMID:
23246173
12.

Tauroursodeoxycholic acid affects PPARγ and TLR4 in Steatotic liver transplantation.

Jiménez-Castro MB, Elias-Miro M, Mendes-Braz M, Lemoine A, Rimola A, Rodés J, Casillas-Ramírez A, Peralta C.

Am J Transplant. 2012 Dec;12(12):3257-71. doi: 10.1111/j.1600-6143.2012.04261.x. Epub 2012 Sep 20.

13.

Retinol binding protein 4 and retinol in steatotic and nonsteatotic rat livers in the setting of partial hepatectomy under ischemia/reperfusion.

Elias-Miró M, Massip-Salcedo M, Raila J, Schweigert F, Mendes-Braz M, Ramalho F, Jiménez-Castro MB, Casillas-Ramírez A, Bermudo R, Rimola A, Rodes J, Peralta C.

Liver Transpl. 2012 Oct;18(10):1198-208. doi: 10.1002/lt.23489.

14.

The road to developing clinical trials: the Barcelona Liver Unit's experience and the dedication to the dream.

Rodés J.

Hepatology. 2013 Mar;57(3):857-66. doi: 10.1002/hep.25833. Epub 2013 Feb 7. No abstract available.

PMID:
22576440
15.

Cyclic adenosine 3',5'-monophosphate in rat steatotic liver transplantation.

Jimenez-Castro MB, Casillas-Ramirez A, Massip-Salcedo M, Elias-Miro M, Serafin A, Rimola A, Rodes J, Peralta C.

Liver Transpl. 2011 Sep;17(9):1099-110. doi: 10.1002/lt.22359.

16.

Retinol-binding protein 4 and peroxisome proliferator-activated receptor-γ in steatotic liver transplantation.

Casillas-Ramírez A, Alfany-Fernández I, Massip-Salcedo M, Juan ME, Planas JM, Serafín A, Pallàs M, Rimola A, Rodés J, Peralta C.

J Pharmacol Exp Ther. 2011 Jul;338(1):143-53. doi: 10.1124/jpet.110.177691. Epub 2011 Apr 12.

PMID:
21487070
17.

[Perception of the physicians regarding the scientific policy in health sciences in Spain].

Rodés J.

Rev Clin Esp. 2011 Apr;211(4):192-3. doi: 10.1016/j.rce.2010.12.004. Epub 2011 Mar 21. Spanish. No abstract available.

PMID:
21420675
18.

Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion.

Ben Mosbah I, Alfany-Fernández I, Martel C, Zaouali MA, Bintanel-Morcillo M, Rimola A, Rodés J, Brenner C, Roselló-Catafau J, Peralta C.

Cell Death Dis. 2010 Jul 8;1:e52. doi: 10.1038/cddis.2010.29.

19.

Improved rat steatotic and nonsteatotic liver preservation by the addition of epidermal growth factor and insulin-like growth factor-I to University of Wisconsin solution.

Zaouali MA, Padrissa-Altés S, Ben Mosbah I, Alfany-Fernandez I, Massip-Salcedo M, Casillas-Ramirez A, Bintanel-Morcillo M, Boillot O, Serafin A, Rimola A, Rodés J, Roselló-Catafau J, Peralta C.

Liver Transpl. 2010 Sep;16(9):1098-111. doi: 10.1002/lt.22126.

20.

Prognostic importance of the cause of renal failure in patients with cirrhosis.

Martín-Llahí M, Guevara M, Torre A, Fagundes C, Restuccia T, Gilabert R, Solá E, Pereira G, Marinelli M, Pavesi M, Fernández J, Rodés J, Arroyo V, Ginès P.

Gastroenterology. 2011 Feb;140(2):488-496.e4. doi: 10.1053/j.gastro.2010.07.043. Epub 2010 Aug 1.

21.

Matrix metalloproteinase 2 in reduced-size liver transplantation: beyond the matrix.

Padrissa-Altés S, Zaouali MA, Franco-Gou R, Bartrons R, Boillot O, Rimola A, Arroyo V, Rodés J, Peralta C, Roselló-Catafau J.

Am J Transplant. 2010 May;10(5):1167-77. doi: 10.1111/j.1600-6143.2010.03092.x. Epub 2010 Mar 26.

22.

Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation.

Ben Mosbah I, Roselló-Catafau J, Alfany-Fernandez I, Rimola A, Parellada PP, Mitjavila MT, Lojek A, Ben Abdennebi H, Boillot O, Rodés J, Peralta C.

Liver Transpl. 2010 Feb;16(2):163-71. doi: 10.1002/lt.21968.

23.

Insulin-like growth factor and epidermal growth factor treatment: new approaches to protecting steatotic livers against ischemia-reperfusion injury.

Casillas-Ramírez A, Zaouali A, Padrissa-Altés S, Ben Mosbah I, Pertosa A, Alfany-Fernández I, Bintanel-Morcillo M, Xaus C, Rimola A, Rodés J, Roselló-Catafau J, Peralta C.

Endocrinology. 2009 Jul;150(7):3153-61. doi: 10.1210/en.2008-1458. Epub 2009 Mar 12.

24.

Effect of angiotensin II and bradykinin inhibition in rat reduced-size liver transplantation.

Padrissa-Altés S, Franco-Gou R, Boillot O, Serafín A, Rimola A, Arroyo V, Rodés J, Peralta C, Roselló-Catafau J.

Liver Transpl. 2009 Mar;15(3):313-20. doi: 10.1002/lt.21693.

25.

Therapeutic targets in liver transplantation: angiotensin II in nonsteatotic grafts and angiotensin-(1-7) in steatotic grafts.

Alfany-Fernandez I, Casillas-Ramirez A, Bintanel-Morcillo M, Brosnihan KB, Ferrario CM, Serafin A, Rimola A, Rodés J, Roselló-Catafau J, Peralta C.

Am J Transplant. 2009 Mar;9(3):439-51. doi: 10.1111/j.1600-6143.2008.02521.x. Epub 2008 Feb 3.

26.

Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion?

Ramalho FS, Alfany-Fernandez I, Casillas-Ramirez A, Massip-Salcedo M, Serafín A, Rimola A, Arroyo V, Rodés J, Roselló-Catafau J, Peralta C.

J Pharmacol Exp Ther. 2009 Apr;329(1):130-40. doi: 10.1124/jpet.108.147835. Epub 2008 Dec 30.

PMID:
19116369
27.

Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic rats.

Melgar-Lesmes P, Tugues S, Ros J, Fernández-Varo G, Morales-Ruiz M, Rodés J, Jiménez W.

Gut. 2009 Feb;58(2):285-92. doi: 10.1136/gut.2008.155028. Epub 2008 Oct 31.

PMID:
18978178
28.

Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.

Martín-Llahí M, Pépin MN, Guevara M, Díaz F, Torre A, Monescillo A, Soriano G, Terra C, Fábrega E, Arroyo V, Rodés J, Ginès P; TAHRS Investigators.

Gastroenterology. 2008 May;134(5):1352-9. doi: 10.1053/j.gastro.2008.02.024. Epub 2008 Feb 14.

PMID:
18471512
29.

[Scientific and technical advances in biomedicine: reflection on clinical management].

Rodés J, Font D, Trilla A, Piqué JM, Gomis R.

Med Clin (Barc). 2008 Apr 19;130(14):553-6. Spanish. No abstract available.

PMID:
18457623
30.

[Organization and functioning model of biomedical research structures. Situation and future challenges].

Font D, Gomis R, Trilla A, Bigorra J, Piqué JM, Rodés J.

Med Clin (Barc). 2008 Apr 12;130(13):510-6. Review. Spanish. No abstract available.

PMID:
18423171
31.

[Medical personnel's careers. A useful incentive system as long as we adhere to its application principles].

Salmerón JM, Benarroch G, Piqué JM, Rodés J.

Med Clin (Barc). 2008 Mar 22;130(10):393-8. Spanish. No abstract available.

PMID:
18381032
32.

Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury.

Casillas-Ramirez A, Amine-Zaouali M, Massip-Salcedo M, Padrissa-Altés S, Bintanel-Morcillo M, Ramalho F, Serafín A, Rimola A, Arroyo V, Rodés J, Roselló-Catafau J, Peralta C.

Crit Care Med. 2008 Apr;36(4):1256-66. doi: 10.1097/CCM.0b013e31816a023c.

PMID:
18379253
33.

[Implementation of clinical management in hospital organization].

Font D, Piqué JM, Guerra F, Rodés J.

Med Clin (Barc). 2008 Mar 15;130(9):351-6. Spanish. No abstract available.

PMID:
18373915
34.

Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion.

Massip-Salcedo M, Zaouali MA, Padrissa-Altés S, Casillas-Ramirez A, Rodés J, Roselló-Catafau J, Peralta C.

Hepatology. 2008 Feb;47(2):461-72.

PMID:
18098300
35.

Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.

Tugues S, Fernandez-Varo G, Muñoz-Luque J, Ros J, Arroyo V, Rodés J, Friedman SL, Carmeliet P, Jiménez W, Morales-Ruiz M.

Hepatology. 2007 Dec;46(6):1919-26.

PMID:
17935226
36.

Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis.

Bogdanos DP, Liaskos C, Pares A, Norman G, Rigopoulou EI, Caballeria L, Dalekos GN, Rodes J, Vergani D.

Hepatology. 2007 Jun;45(6):1583; author reply 1583-4. No abstract available.

PMID:
17538935
37.

Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease.

Monegal A, Navasa M, Peris P, Alvarez L, Pons F, Rodés J, Guañabens N.

Liver Int. 2007 May;27(4):492-7.

PMID:
17403189
38.

Impaired extracellular matrix degradation in aortic vessels of cirrhotic rats.

Fernández-Varo G, Morales-Ruiz M, Ros J, Tugues S, Muñoz-Luque J, Casals G, Arroyo V, Rodés J, Jiménez W.

J Hepatol. 2007 Mar;46(3):440-6. Epub 2006 Nov 13.

PMID:
17156884
39.

Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA.

González-Périz A, Planagumà A, Gronert K, Miquel R, López-Parra M, Titos E, Horrillo R, Ferré N, Deulofeu R, Arroyo V, Rodés J, Clària J.

FASEB J. 2006 Dec;20(14):2537-9. Epub 2006 Oct 20.

PMID:
17056761
40.

Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren's syndrome.

Ramos-Casals M, Sánchez-Tapias JM, Parés A, Forns X, Brito-Zerón P, Nardi N, Vazquez P, Vélez D, Arias I, Bové A, Plaza J, Rodés J, Font J.

J Rheumatol. 2006 Aug;33(8):1593-9.

PMID:
16881116
41.

Gene expression profiling of renal dysfunction in rats with experimental cirrhosis.

López-Parra M, Telleria N, Titos E, Planagumà A, González-Périz A, Arroyo V, Rodés J, Clària J.

J Hepatol. 2006 Aug;45(2):221-9. Epub 2006 Apr 7.

PMID:
16644059
42.
43.

Treatment of primary biliary cirrhosis.

Parés A, Rodés J.

Minerva Gastroenterol Dietol. 2000 Sep;46(3):165-74.

PMID:
16498378
44.

Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score.

Terra C, Guevara M, Torre A, Gilabert R, Fernández J, Martín-Llahí M, Baccaro ME, Navasa M, Bru C, Arroyo V, Rodés J, Ginès P.

Gastroenterology. 2005 Dec;129(6):1944-53.

PMID:
16344063
45.

Microarray analysis of endothelial differentially expressed genes in liver of cirrhotic rats.

Tugues S, Morales-Ruiz M, Fernandez-Varo G, Ros J, Arteta D, Muñoz-Luque J, Arroyo V, Rodés J, Jiménez W.

Gastroenterology. 2005 Nov;129(5):1686-95.

PMID:
16285966
46.

Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature.

Ramos-Casals M, Pares A, Jara LJ, Solans R, Viñas O, Vázquez P, Sánchez-Tapias JM, Rodés J, Font J; HISPAMEC Study Group*.

J Viral Hepat. 2005 Nov;12(6):648-54. Review.

PMID:
16255767
47.

Sustained aquaretic effect of the V2-AVP receptor antagonist, RWJ-351647, in cirrhotic rats with ascites and water retention.

Ros J, Fernández-Varo G, Muñoz-Luque J, Arroyo V, Rodés J, Gunnet JW, Demarest KT, Jiménez W.

Br J Pharmacol. 2005 Nov;146(5):654-61.

48.

Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation.

Carrasco-Chaumel E, Roselló-Catafau J, Bartrons R, Franco-Gou R, Xaus C, Casillas A, Gelpí E, Rodés J, Peralta C.

J Hepatol. 2005 Dec;43(6):997-1006. Epub 2005 Jun 27.

PMID:
16085333
49.

Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells.

Titos E, Clària J, Planagumà A, López-Parra M, González-Périz A, Gaya J, Miquel R, Arroyo V, Rodés J.

J Leukoc Biol. 2005 Oct;78(4):871-8. Epub 2005 Jul 20.

PMID:
16033810
50.

Early negative T waves and viable myocardium in patients with a first ST-elevation acute coronary syndrome.

Figueras J, Cortadellas J, Rodés J, Domingo E, Castell J, Soler JS.

J Electrocardiol. 2005 Jul;38(3):171-8.

PMID:
16003695

Supplemental Content

Support Center